| Lastest Insider Transactions Of Aquestive Therapeutics, Inc. ( AQST ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2019-11-30 | Option Exercise | 14,572 | 0.00 | 0 | 2019-12-02 16:56:31 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2019-11-30 | Option Exercise | 14,572 | 0.00 | 0 | 2019-12-02 16:56:03 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2019-09-30 | Option Exercise | 329 | 0.00 | 0 | 2019-10-02 16:33:51 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2019-09-30 | Option Exercise | 329 | 0.00 | 0 | 2019-10-02 16:33:19 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2019-08-31 | Option Exercise | 14,572 | 0.00 | 0 | 2019-09-03 18:09:22 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2019-08-31 | Option Exercise | 14,572 | 0.00 | 0 | 2019-09-03 18:09:06 |
| AQST | Aquestive Therapeutics, Inc. | Barber Daniel | SVP-Chief Operating Officer | 2019-08-27 | Buy | 2,000 | 3.99 | 7,980 | 2019-08-27 21:49:13 |
| AQST | Aquestive Therapeutics, Inc. | Scibetta James S | Directior | 2019-08-19 | Buy | 22,971 | 3.79 | 86,977 | 2019-08-22 16:30:15 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2019-08-09 | Buy | 8,000 | 3.87 | 30,987 | 2019-08-20 16:30:12 |
| AQST | Aquestive Therapeutics, Inc. | Wood Theresa | SVP-HR and Org. Development | 2019-08-09 | Buy | 1,000 | 3.99 | 3,990 | 2019-08-13 16:30:17 |
| AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | SVP, General Counsel | 2019-08-09 | Buy | 10,000 | 4.07 | 40,747 | 2019-08-13 16:30:14 |
| AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | SVP-Bus. Process & Info. Tech. | 2019-08-12 | Buy | 600 | 3.81 | 2,286 | 2019-08-13 16:30:12 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2019-06-30 | Option Exercise | 329 | 0.00 | 0 | 2019-07-02 16:30:15 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2019-06-30 | Option Exercise | 329 | 0.00 | 0 | 2019-07-02 16:30:12 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2019-05-31 | Option Exercise | 14,572 | 0.00 | 0 | 2019-06-03 16:15:16 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2019-05-31 | Option Exercise | 14,572 | 0.00 | 0 | 2019-06-03 16:15:12 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2019-03-31 | Option Exercise | 329 | 0.00 | 0 | 2019-04-01 16:40:57 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2019-03-31 | Option Exercise | 329 | 0.00 | 0 | 2019-04-01 16:40:23 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2019-02-28 | Option Exercise | 14,572 | 0.00 | 0 | 2019-03-01 17:24:11 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2019-02-28 | Option Exercise | 14,572 | 0.00 | 0 | 2019-03-01 17:23:55 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2018-12-31 | Option Exercise | 329 | 0.00 | 0 | 2019-01-03 17:30:00 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2018-12-31 | Option Exercise | 329 | 0.00 | 0 | 2019-01-03 17:23:36 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2018-12-10 | Buy | 1,000 | 7.78 | 7,780 | 2018-12-11 17:41:13 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2018-12-06 | Buy | 2,000 | 8.69 | 17,380 | 2018-12-10 17:47:07 |
| AQST | Aquestive Therapeutics, Inc. | Barber Daniel | SVP-Chief Strategy/Dev Officer | 2018-12-10 | Buy | 1,000 | 8.00 | 8,000 | 2018-12-10 17:46:20 |
| AQST | Aquestive Therapeutics, Inc. | Maxwell John T. | SVP-Chief Financial Officer | 2018-12-06 | Buy | 5,000 | 8.87 | 44,350 | 2018-12-07 16:27:58 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2018-11-30 | Option Exercise | 14,572 | 0.00 | 0 | 2018-12-04 16:05:07 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2018-11-30 | Option Exercise | 14,572 | 0.00 | 0 | 2018-12-04 16:02:51 |
| AQST | Aquestive Therapeutics, Inc. | Marshall Ken W. | Commercial Leader | 2018-11-21 | Buy | 1,445 | 10.15 | 14,667 | 2018-12-03 16:01:29 |
| AQST | Aquestive Therapeutics, Inc. | BRAENDER LORI J | General Counsel | 2018-11-27 | Buy | 1,000 | 10.57 | 10,570 | 2018-11-29 16:01:45 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2018-11-27 | Buy | 1,000 | 9.87 | 9,870 | 2018-11-28 16:01:31 |
| AQST | Aquestive Therapeutics, Inc. | Wood Theresa | SVP-HR and Org. Development | 2018-11-26 | Buy | 500 | 10.34 | 5,170 | 2018-11-26 14:53:20 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2018-11-21 | Buy | 1,000 | 10.25 | 10,250 | 2018-11-26 13:43:06 |
| AQST | Aquestive Therapeutics, Inc. | Maxwell John T. | SVP-Chief Financial Officer | 2018-11-21 | Buy | 10,000 | 9.80 | 98,000 | 2018-11-26 13:39:56 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2018-11-21 | Buy | 7,950 | 10.10 | 80,325 | 2018-11-26 13:38:01 |
| AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | SVP-Operations/Value Delivery | 2018-11-21 | Buy | 200 | 9.98 | 1,996 | 2018-11-26 13:35:15 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2018-09-30 | Option Exercise | 329 | 0.00 | 0 | 2018-10-02 16:38:53 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2018-09-30 | Option Exercise | 329 | 0.00 | 0 | 2018-10-02 16:37:04 |
| AQST | Aquestive Therapeutics, Inc. | Kendall Keith J | CEO and President | 2018-08-31 | Option Exercise | 14,572 | 0.00 | 0 | 2018-09-05 17:41:54 |
| AQST | Aquestive Therapeutics, Inc. | Schobel Alexander Mark | Chief Innovation/Tech Officer | 2018-08-31 | Option Exercise | 14,572 | 0.00 | 0 | 2018-09-05 17:39:56 |
| AQST | Aquestive Therapeutics, Inc. | BRATTON DOUGLAS K | Directior 10% Owner | 2018-07-24 | Buy | 165,000 | 15.00 | 2,475,000 | 2018-07-26 14:59:47 |
